AKARI THERAPEUTICS 24 HOUR DEADLINE ALERT: APPROXIMATELY 24 HOURS REMAIN; CLAIMSFILER REMINDS INVESTORS of Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc – (AKTX)

NEW ORLEANS, July 10, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until July 11, 2017 to file lead plaintiff applications in a securities class action lawsuit against Akari Therapeutics, Plc (Nasdaq:AKTX). Investor losses must relate to purchases of the Company’s securities between March 30, 2017 and May 11, 2017.  This action is pending in the United States District Court for the Southern District of New York.

Get Help

Akari Therapeutics investors should visit https://www.claimsfiler.com/cases/view-akari-therapeutics-plc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.  

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.

To learn more about ClaimsFiler, visit www.claimsfiler.com.